The association of peripheral monocyte derived interleukin 1β (IL- 1β), IL-1 receptor antagonist, and tumor necrosis factor-α with osteoarthritis in the elderly

Journal of Rheumatology

Volumn 25, Issue 9, 1998, Pages 1820-1826

  Fraenkel, Liana ^a,c   Roubenoff, Ronenn ^b   LaValley, Michael ^a   McAlindon, Timothy ^c   Chaisson, Christine ^c   Evans, Stephen ^c   Harris, Tamara ^d   Dinarello, Charles A ^b   Felson, David T ^a  

^a BOSTON UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Blood; Cohort study; Cytokines; Osteoarthritis

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; OSTEOPHYTE; PRIORITY JOURNAL; RADIODIAGNOSIS; SCORING SYSTEM; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HAND; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MONOCYTES; OSTEOARTHRITIS; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031787464     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Chikanza IC, Roux-Lombard P, Dayer JM, Panayi GS. Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:642-8.
2. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994;70:807-15.
3. Arend PA, Dayer JM. Cytokines and cytokine inhibitors or agonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
4. Pelletier JP, Faure MP, DiBattista JA, Wilhelm S, Visco D, Martel-Pelletier J. Coordinate synthesis of stromelysins, interleukin-1, and oncogene proteins in experimental osteoarthritis. Am J Pathol 1993;142:95-105.
5. Barkley DEH, Feldmann M, Maini RN. Cells with dendritic morphology and bright interleukin-1 alpha staining circulate in the blood of patients with rheumatoid arthritis. Clin Exp Immunol 1990;80:25-31.
6. Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
7. Deleuran BW, Chu CQ, Field M, et al. Localization of interleukin-1 alpha, type 1 interleukin receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 1992;31:801-9.
8. Shinmei M, Masuda K, Kikuchi T, Shimomura Y, Okada Y. Production of cytokines by chondrocytes and its role in proteoglycan degradation. J Rheumatol 1991;18 Suppl 27:89-91.
9. Smith MD, Triantafillou S, Parker A, Youssef PP, Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997;24:365-71.
10. Huet G, Flipo RM, Colin C, et al. Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor alpha and interleukin-1. Arthritis Rheum 1993;36:772-80.
11. Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J. Synthesis of metalloproteases and interleukin-6 in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol 1995;22 Suppl 43:109-14.
12. Campbell IK, Piccoli DS, Roberts MJ, Muirden KD, Hamilton JA. Effects of tumor necrosis factor alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis Rheum 1990;33:542-52.
13. Ismaiel S, Atkins RM, Pearse MF, Dieppe PA, Elson CJ. Susceptibility of normal and arthritic human articular cartilage to degradative stimuli. Br J Rheumatol 1992;31:369-73.
14. Pujol JP, Galera P, Redini F, Mauviel A, Loyau G. Role of cytokines in osteoarthritis: comparative effects of interleukin-1 and transforming growth factor beta on cultured rabbit articular chondrocytes. J Rheumatol 1991;18 Suppl 27:76-9.
15. Van de Loo AAJ, Arntz OJ, Otterness IG, van den Berg WB. Proteoglycan loss and subsequent replenishment in articular cartilage after mild arthritic insult by IL-1 in mice: impaired proteoglycan turnover in the recovery phase. Agents Actions 1994;41:200-8.
16. Wolfe GC, MacNaul KL, Buechel FF, et al. Differential in vivo expression of collagenase mRNA in synovium and cartilage. Arthritis Rheum 1993;36:1540-7.
17. Firestein GS, Boyle DL, Yu C, et al. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994;37:644-52.
18. Pelletier JP, Caron JP, Evans C, et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997;40:1012-9.
19. Loose LD, de Oliveira R, Sipe JD, Franzblau C, Shanahan WR. A possible systemic component of osteoarthritis: elevated concentrations (by ELISA) of C-reactive protein in serum of OA patients and modulation by tenidap [abstract]. Arthritis Rheum 1993;36 Suppl 9:S166.
20. Spector TD, Hart DJ, Nandra D, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997;40:723-7.
21. Wolfe F. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J Rheumatol 1997;24:1486-8.
22. Roubenoff R, Roubenoff RA, Cannon JG, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93:2379-86.
23. Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellman DB. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol 1992;19:1505-10.
24. Cannon JG, van der Meer JWM, Kwiatkowski D, et al. Interleukin-1 in human plasma: optimization of collection, plasma extraction, and radioimmunoassay methods. Lymphokine Res 1988;7:457-67.
25. Rail LC, Rosen CJ, Dolnikowski G, et al. Protein metabolism and its mediators before and after strength training in aging and chronic inflammation. Arthritis Rheum 1996;39:1115-24.
26. Roubenoff RR, Harris TB, Abad LW, Wilson PF, Dallai GE, Dinarello CA. Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol 1998;56A:M20-M26.
27. Danis VA, March LM, Nelson DS, Brooks PM. Interleukin-1 secretion by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis. J Rheumatol 1987;14:33-9.
28. Goto M, Fujisawa M, Yamada A, et al. Spontaneous release of angiotensin converting enzyme and interleukin-1 beta from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition. Ann Rheum Dis 1990;49:172-6.
29. Zangerle PF, DeGroote D, Lopez M, et al. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IFN-γ, and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 1992;4:568-75.
30. Felson DT, Zhang Y, Hannan MT, et al. The incidence and natural history of knee osteoarthritis in the elderly: The Framingham Osteoarthritis Study. Arthritis Rheum 1995;38:1500-5.
31. Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly: The Framingham Osteoarthritis Study. Arthritis Rheum 1987;30:914-8.
32. McAlindon TE, Jacques P, Zhang Y, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis. Arthritis Rheum 1996;39:648-56.
33. Schindler R, Clark BD, Dinarello CA. Dissociation between interleukin-1 mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem 1990;265:10232-7.
34. Endres S, Cannon JG, Ghorbani R, et al. In vitro production of IL-α, IL-1β, TNF-α, and IL-2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 1989;19:2327-33.
35. Dinarello CA, Lonnemann G, Maxwell R, Shaldon S. Ultrafiltration to reject human interleukin-1 inducing substances derived from bacterial cultures. J Clin Microbiol 1987;25:1233-8.
36. Lisi PJ, Chu CW, Koch GA, et al. Development and use of a radioimmunoassay for human interleukin-1β. Lymphokine Res 1987;6:229-44.
37. Poutsiaka DD, Clark BD, Vannier E, Dinarello CA. Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. Blood 1991;78:1275-81.
38. Van der Meer JWM, Endres S, Lonnemann G, et al. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol 1988;43:216-23.
39. Sipe JD, Bartle LM, Loose LD. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response. J Immunol 1992;148:480-4.
40. Cameron ML, Fu FH, Paessler HH, Schneider M, Evans CH. Synovial fluid cytokine concentrations as possible prognostic indicators in the ACL-deficient knee. Knee Surg Sports Traumatol Arthrosc 1994;2:38-44.
41. Gonzalez E, de la Cruz C, de Nicolas R, Egido J, Herrero-Beaumont G. Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions 1994;41:171-8.
42. Pacifici R, Rifas L, McCracken R, et al. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 1989;86:2398-402.
43. Zhang YQ, McAlindon T, Hannan MT, Felson DT. A longitudinal study of the relation of estrogen replacement therapy to the risk of radiographic knee osteoarthritis [abstract]. Arthritis Rheum 1995;38 Suppl 9:S269.
44. Rothman KJ, Greenland S. Fundamentals of epidemiologic data analysis. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd edition. Philadelphia: Lippencott-Raven; 1986:225-9.
45. Sipe JD. Acute phase proteins in osteoarthritis. Semin Arthritis Rheum 1995;25:75-86.
46. Larbre JP, Da Silva JAP, Moore AR, James IT, Scott JDL, Willoughby DA. Cartilage contribution to gender differences in joint disease progression: a study with rat articular cartilage. Clin Exp Rheumatol 1994;12:401-8.
47. Pacifici R, Rifas L, McCracken R, Avioli LV. The role of interleukin 1 in post menopausal bone loss. Exp Gerontol 1990;25:309-16.
48. Aiura K, Clark BD, Dinarello CA, et al. Interaction with autologous platelets multiplies interleukin-1 and tumor necrosis factor production in mononuclear cells. J Infect Dis 1997;175:123-9.